The J&J vaccine made it easier for some clinics to serve their communities. Many are concerned about getting patients to return for a second shot of the two dose vaccines. (April 14)
KEN GRIFFIN: The health-care community and vaccinations has had a very disenfranchised historical relationship. Having the one shot allows those individuals to come in and obtain one shot and they are done. And they are now having the 60% to 70% efficacy of the vaccination. So now that we don't have access to the one shot, it's going to be harder to try to make sure people come in for the second doses.
Having a one dose allows us to have those folks come in one time to receive that vaccination without having the pressure of coming back for another vaccination. I feel that it's necessary to provide this extra protection and caution to the community that we are giving this vaccination to. So I do understand the pause in it. Getting more research done about the J&J vaccine will help improve the trust that we have with the vaccine. So I do understand that the pause is necessary just to provide a little more caution to the community.